Diabetes in India explained

India has an estimated 100 million [1] people (1 in 10 Indians) formally diagnosed with diabetes, which makes it the second most affected in the world, after China.[2] Furthermore, 700,000 Indians died of diabetes, hyperglycemia, kidney disease or other complications of diabetes in 2020. One in six people (17%) in the world with diabetes is from India.[2] (India’s population as calculated in October 2018 was about 17.5% of the global total.[3]) The number is projected to grow by 2045 to become 134 million per the International Diabetes Federation.

In India, type 1 diabetes is rarer than in western countries, and about 90 to 95% of Indians who were diagnosed had type 2 diabetes. Only about one-third of type 2 diabetics in India have a body mass index above 25.[4] A 2004 study suggests that the prevalence of type 2 diabetes in Indians may be due to environmental and lifestyle changes resulting from industrialization and migration to urban environment from rural.[5] This lifestyle change has led to the increased consumption of energy intake from animal foods in Asian populations.[6] This change has been seen in India where urban residents consumed 32% of energy from animal fats compared to 17% of rural residents.[7] These changes also occur earlier in life, which means chronic long-term complications are more common.

Epidemiology

In 2020, according to the International Diabetes Federation (IDF), 463 million people have diabetes in the world and 88 million people in the Southeast Asia region. Of this 88 million people, 77 million belong to India.[8] The prevalence of diabetes in the population is 8.9%, according to the IDF. According to the IDF estimates, India has the second highest number of children with type 1 diabetes after the United States. It also contributes to the largest proportion of incident cases of type 1 diabetes in children in the SEA region.[9] Per the World Health Organization, 2% of all deaths in India are due to diabetes.[10]

The number of people with diabetes in India has increased from 26 million in 1990 to 65 million in 2016.[11] According to the 2019 National Diabetes and Diabetic Retinopathy Survey report released by the Ministry of Health and Family Welfare, the prevalence was found to be 11.8% in people over the age of 50.[12] The prevalence of diabetes is 6.5% and prediabetes 5.7% among the adults below the age of 50 years, according to the DHS survey.[13] The prevalence was similar in both male (12%) and female (11.7%) populations. It was higher in urban areas.[14] When surveyed for diabetic retinopathy, which threatens eyesight, 16.9% of the diabetic population aged up to 50 years were found to be affected. Per the report, diabetic retinopathy in the 60-69-years age group was 18.6%, in the 70-79-years age group it was 18.3%, and in those over 80 years of age it was 18.4%. A lower prevalence of 14.3% was observed in the 50-59-years age group. High prevalence of diabetes is reported in economically and epidemiologically advanced states such as Tamil Nadu and Kerala, where many research institutes which conduct prevalence studies are also present.[15]

There are four sub-groups or clusters of people with type 2 diabetes in India, two of which are unique to the country. These sub-groups have different risk levels of complications and might need different treatments.[16] [17]

Diabetes-related disease burden

Over the past three decades, the burden of diabetes in terms of deaths and Disability-adjusted life year (DALYs) has more than doubled in India. As per the Global Burden of Disease (GBD) Data Visualizations, the recorded death rate and DALY rate of diabetes in 2019 were 19.64 per 100,000 and 919.02 per 100,000 population, respectively, including males and females.[18] The GBD explore risk assessment framework estimated that diabetes-related DALYs attributable to high risk for Stroke, Coronary artery disease, Chronic obstructive pulmonary disease, Chronic kidney disease, Diarrhoeal diseases, Lower respiratory tract infection, Dietary iron deficiency, and Neonatal disorders.[19]

According to a survey conducted in 2016, the High body mass index (BMI) appeared to be the major risk factor contributing to 36% of diabetes DALYs. Besides, other risk factors, such as dietary risk, tobacco consumption, occupational exposure to passive smoke, low physical activity, and alcohol consumption, played a significant role as contributing risk factors.[20]

Prevention

The majority of diabetes cases are of type 2 diabetes.[21] In order to control diabetes in India, the Government of India initiated the National Program for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke (NPCDCS) in 2010. It aims to set up outreach camps for opportunistic screening at all levels in the health care delivery system for early detection of diabetes, among other illnesses.[22]

Preventing diabetes in the developing nations is valued highly because of the high cost of treating it. In India, it is estimated that a diabetic person spends a median of for medical treatment. Pragmatic, cost-effective strategies for primary prevention of diabetes is necessary. Studies using information technology were tested. In one such program, SMS was used to motivate people with impaired glucose tolerance (IGT) to follow lifestyle modification (LSM). This was found to be effective with a relative risk reduction of 36% compared to the participants who had only standard care.[23]

Indian Diabetes Prevention Program

The Indian Diabetes Prevention Program is a three-year randomized control trial that employed LSM and metformin (Met) to prevent type 2 diabetes in subjects with IGT. It concluded that LSM and Met were cost-effective interventions for preventing diabetes among high-risk individuals in India and other developing countries.[24]

National Diabetes Control Program

The National Diabetes Control Program was initiated in 1987 in some districts of Tamil Nadu, Jammu and Kashmir, and Karnataka. Its objectives included:[25]

However, the program was not expanded to other states due to shortage of funds.

See also

References

Dr.Dinesh Kacha https://en.wikipedia.org/wiki/Outline_of_diabetesObjective:- To Understand, Detect, Diagnose & Prevent Type 2 Diabetes To Understand The Root Cause of Type 2 Diabetes To Identify Insulin Resistance Mechanism Dr. Dinesh Kacha addresses the root cause of insulin resistance and lack of insulin, reversing diabetes through ayurvedic lifestyle & fixing the metabolic damage https://figshare.com/articles/journal_contribution/_em_strong_Dr_Dinesh_Kacha_Presents_Diabetes_Reversal_Through_Ayurvedic_Lifestyle_strong_em_/23055494

Notes and References

  1. News: Lancet study: More than 100 million people in India diabetic. BBC. 9 June 2023 . 9 June 2023.
  2. News: Kannan. Ramya. India is home to 77 million diabetics, second highest in the world. 2019-11-14. The Hindu. 2020-04-29. en-IN. 0971-751X.
  3. Web site: Countries By Percentage Of World Population . Geoffrey Migiro . October 25, 2018 . WorldAtlas . May 19, 2020 .
  4. Web site: 2019-01-15 . Over 30 million have now been diagnosed with diabetes in India. The CPR (Crude prevalence rate) in the urban areas of India is thought to be 9 per cent. . 2020-04-29 . Diabetes . en-GB.
  5. Mohan. V.. June 2004. Why are Indians more prone to Diabetes?. The Journal of the Association of Physicians of India. 52. 468–474. 0004-5772. 15645957.
  6. May 27, 2009 . Diabetes in Asia . American Medical Association . 301 . 20 . JAMA Network.
  7. Prakash . Shetty . 2002 . Nutrition transition in India . Cambridge University Press . 5 . 1A . 175–182 . Public Health Nutrition.
  8. Web site: Members. idf.org. 2020-04-29.
  9. Ramachandran. Ambady. Snehalatha. Chamukuttan. Ma. Ronald Ching Wan. 2014-02-01. Diabetes in South-East Asia: An update. Diabetes Research and Clinical Practice. en. 103. 2. 231–237. 10.1016/j.diabres.2013.11.011. 0168-8227. 24300015. 33810939 .
  10. Web site: Diabetes country profiles - World Health Organization. who.int. 30 April 2020.
  11. Tandon. Nikhil. Anjana. Ranjit M.. Mohan. Viswanathan. Kaur. Tanvir. Afshin. Ashkan. Ong. Kanyin. Mukhopadhyay. Satinath. Thomas. Nihal. Bhatia. Eesh. Krishnan. Anand. Mathur. Prashant. 2018-12-01. The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990–2016. The Lancet Global Health. en. 6. 12. e1352–e1362. 10.1016/S2214-109X(18)30387-5. 2214-109X. 30219315. 6227383.
  12. Web site: Government survey found 11.8% prevalence of diabetes in India. Sharma. Neetu Chandra. 2019-10-10. Livemint. en. 2020-04-29.
  13. Chandrupatla. Siddardha Gowtam. Khalid. Isma. Muthuluri. Tejdeep. Dantala. Satyanarayana. Tavares. Mary. 2020-09-18. Diabetes and prediabetes Prevalence Among Young and Middle Aged Adults, And Geographic Differences In India- National Family Health Survey. Epidemiology and Health. 42 . e2020065. 32972049. 10.4178/epih.e2020065. 7871157 . 2092-7193. free.
  14. Web site: Diabetes in India . en-US. 2020-04-29. Cadi Research.
  15. Atre. Sachin. 2019-04-01. The burden of diabetes in India. The Lancet Global Health. en. 7. 4. e418. 10.1016/S2214-109X(18)30556-4. 2214-109X. 30879507. free.
  16. 2021-03-04 . New sub-groups of diabetes could lead to more targeted treatment for people in India . NIHR Evidence . Plain English summary . en . National Institute for Health and Care Research . 10.3310/alert_45105. 241327246 .
  17. Anjana . Ranjit Mohan . Baskar . Viswanathan . Nair . Anand Thakarakkattil Narayanan . Jebarani . Saravanan . Siddiqui . Moneeza Kalhan . Pradeepa . Rajendra . Unnikrishnan . Ranjit . Palmer . Colin . Pearson . Ewan . Mohan . Viswanathan . 17 August 2020 . Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: a data-driven cluster analysis: the INSPIRED study . BMJ Open Diabetes Research & Care . en . 8 . 1 . e001506 . 10.1136/bmjdrc-2020-001506 . 2052-4897 . 7437708 . 32816869.
  18. Web site: Institute for Health Metrics and Evaluation GBD compare data visualization. Healthdata.org. 2021-09-12.
  19. Web site: Institute for Health Metrics and Evaluation GBD compare data visualization. Healthdata.org. 2021-09-12.
  20. Tandon. Nikhil. Anjana. Ranjit M.. Mohan. Viswanathan. Kaur. Tanvir. Afshin. Ashkan. Ong. Kanyin. Mukhopadhyay. Satinath. Thomas. Nihal. Bhatia. Eesh. Krishnan. Anand. Mathur. Prashant. 2018-12-01. The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990–2016. The Lancet Global Health. en. 6. 12. e1352–e1362. 10.1016/S2214-109X(18)30387-5. 2214-109X. 30219315. 6227383.
  21. Atre. Sachin. September 2015. Addressing policy needs for prevention and control of type 2 diabetes in India. Perspectives in Public Health. 135. 5. 257–263. 10.1177/1757913914565197. 1757-9147. 25585513. 32092695 .
  22. Web site: National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke. Directorate General Of Health Services. 2020-04-29.
  23. Ramachandran. Ambady. Snehalatha. Chamukuttan. 2014-05-01. Prevention of diabetes: How far have we gone?. Indian Journal of Endocrinology and Metabolism. en. 18. 3. 252–3. 10.4103/2230-8210.131112. 2230-8210. 24944915. 4056119 . free .
  24. 1 August 2007. Cost effectiveness of prevention of diabetes. Indian Diabetes Prevention Programme. 13.
  25. Verma. Ramesh. Khanna. Pardeep. Mehta. Bharti. 2012-06-30. National programme on prevention and control of diabetes in India: Need to focus. The Australasian Medical Journal. 5. 6. 310–315. 10.4066/AMJ.2012.1340. 1836-1935. 3395295. 22848329.